Core Alternative Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Sell |
3,132
-739
| -19% | -$300K | 0.35% | 61 |
|
|
2025
Q1 | $1.93M | Sell |
3,871
-40
| -1% | -$19.9K | 0.46% | 62 |
|
|
2024
Q4 | $2.03M | Sell |
3,911
-393
| -9% | -$204K | 0.43% | 61 |
|
|
2024
Q3 | $2.66M | Buy |
4,304
+2
| +0% | +$1.24K | 0.51% | 60 |
|
|
2024
Q2 | $2.38M | Buy |
4,302
+8
| +0.2% | +$4.42K | 0.48% | 60 |
|
|
2024
Q1 | $2.5M | Sell |
4,294
-72
| -2% | -$41.8K | 0.45% | 60 |
|
|
2023
Q4 | $2.32M | Sell |
4,366
-187
| -4% | -$99.3K | 0.4% | 61 |
|
|
2023
Q3 | $2.3M | Buy |
4,553
+387
| +9% | +$196K | 0.36% | 59 |
|
|
2023
Q2 | $2.17M | Buy |
4,166
+165
| +4% | +$86.1K | 0.32% | 62 |
|
|
2023
Q1 | $2.31M | Sell |
4,001
-762
| -16% | -$439K | 0.31% | 60 |
|
|
2022
Q4 | $2.62M | Sell |
4,763
-1
| -0% | -$551 | 0.33% | 52 |
|
|
2022
Q3 | $2.42M | Buy |
4,764
+887
| +23% | +$450K | 0.39% | 47 |
|
|
2022
Q2 | $2.11M | Buy |
3,877
+1,363
| +54% | +$740K | 0.5% | 44 |
|
|
2022
Q1 | $1.49M | Buy |
2,514
+1,848
| +277% | +$1.09M | 0.4% | 44 |
|
|
2021
Q4 | $444K | Buy |
666
+619
| +1,317% | +$413K | 0.09% | 69 |
|
|
2021
Q3 | $27K | Buy |
+47
| New | +$27K | 0.01% | 84 |
|